The Director of Oncology US Market Access Marketing will lead market access marketing strategy for VENCLEXTA (venetoclax), an oral oncolytic jointly commercialized by AbbVie and Genentech. VENCLEXTA is approved for Chronic Lymphocytic Leukemia (CLL) and Acute Myeloid Leukemia (AML). The role leads market access strategy and manages two direct reports. It is accountable for contracting and customer engagement strategy across payer channels, including Commercial, Medicare, Medicaid, and VA, as well as GPO and Community Oncology. The Director aligns with the Market Access field and coordinates strategy, communication, and alignment across US Market Access Channel and Policy teams. As the Market Access Marketing subject matter expert for the VENCLEXTA Integrated Brand Teams, the Director develops strategies with stakeholders in the Oncology commercial organization and US Medical Affairs. The Director manages market access interactions and collaborative relationships with relevant Genentech staff, including joint commercialization council decision-making with senior leaders from both companies. The role leads market access components of key account strategy development across AbbVie and Genentech, translating VENCLEXTA’s clinical and economic profile into value stories and resources for payer, provider institution, government, and community segments. The Director uses data, analytics, and strategic thinking to lead the marketing component of the business, provide positive leadership, and support cultural alignment with US Market Access’s Ambitious Cultural Vision.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director